Table 1

Demographic information of the patients in each group

DemographicsWithin 3 months(1st group)3–6 months(2nd group)6–9 months(3rd group)9–12 months(4th group)12–24 months(5th group)24–60 months(6th group)>60 months(7th group)
Sex
 Male eyes12132233424234
 Female eyes0050747
Age, years19.42±6.5717.77±4.0715.00±4.7318.61±5.7917.67±4.4120.24±5.2625.20±8.34
Disease duration, months1.75±0.974.31±0.487.70±1.1411.00±0.8718.51±4.0839.11±8.74118.76±67.20
BCVA (LogMAR)1.65±0.441.58±0.441.71±0.371.79±0.421.64±0.511.75±0.391.49±0.36
  • BCVA, best-corrected visual acuity; LogMAR, logarithm of the minimum angle of resolution; 1st group, disease duration ≤3 months; 2nd group, disease duration 3–6 months; 3rd group, disease duration 6–9 months; 4th group, disease duration 9–12 months; 5th group, disease duration 12–24 months; 6th group, disease duration 24–60 months; 7th group, disease duration >60 months.